Advances in treatment of ACS

Session comprising selected EuroPCR 2016 late-breaking trial submissions

Chairpersons: S. James, M. Roffi

Presentations available when logged in:

  • Contemporary trends and outcomes associated with the preprocedural use of oral P2Y12 inhibitors in patients undergoing PCI
  • Safety of a regional standardised protocol to optimise the use of most effective platelet inhibition in ACS treated with PCI: final results from th...
  • Assessment of the plaque characteristics by OCT in patients presenting with ACS: insights from the OCT-FORMIDABLE registry
  • 18-month clinical follow-up of the BRS STEMI FIRST study
  • Long-term follow-up after BRS implantation in STEMI patients - PRAGUE-19 study update
  • Safety and efficacy of biodegradable polymer DES in management of patients with acute STEMI: MASTER study - one-year clinical outcomes